JPH0460120B2 - - Google Patents
Info
- Publication number
- JPH0460120B2 JPH0460120B2 JP13905783A JP13905783A JPH0460120B2 JP H0460120 B2 JPH0460120 B2 JP H0460120B2 JP 13905783 A JP13905783 A JP 13905783A JP 13905783 A JP13905783 A JP 13905783A JP H0460120 B2 JPH0460120 B2 JP H0460120B2
- Authority
- JP
- Japan
- Prior art keywords
- sugar
- group
- derivative
- anomeric position
- anomeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 aliphatic alcohols Chemical class 0.000 claims description 38
- 235000000346 sugar Nutrition 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 3
- 150000001879 copper Chemical class 0.000 claims description 3
- 150000002314 glycerols Chemical class 0.000 claims description 3
- DQIMSUZRBYLFOT-UHFFFAOYSA-N hydroxy-dimethyl-sulfanylidene-$l^{5}-phosphane Chemical group CP(C)(O)=S DQIMSUZRBYLFOT-UHFFFAOYSA-N 0.000 claims description 3
- 125000001976 hemiacetal group Chemical group 0.000 claims description 2
- 150000002730 mercury Chemical class 0.000 claims description 2
- 150000003378 silver Chemical class 0.000 claims description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- UHFIMVQOGRRZRM-UHFFFAOYSA-N hydroxy-diphenyl-sulfanylidene-$l^{5}-phosphane Chemical group C=1C=CC=CC=1P(=S)(O)C1=CC=CC=C1 UHFIMVQOGRRZRM-UHFFFAOYSA-N 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- 238000000034 method Methods 0.000 description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 150000008163 sugars Chemical class 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 5
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- BPMIHKHNNNNQIO-YFEREJOUSA-N (3r,4s,5r,6r)-3,4,5-tribenzyl-6-(1-hydroxy-2-phenylethyl)oxane-2,3,4,5-tetrol Chemical compound OC([C@@H]1[C@]([C@@](O)(CC=2C=CC=CC=2)[C@](O)(CC=2C=CC=CC=2)C(O)O1)(O)CC=1C=CC=CC=1)CC1=CC=CC=C1 BPMIHKHNNNNQIO-YFEREJOUSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- UGOLAPHJCTVIEW-UHFFFAOYSA-N chloro-dimethyl-sulfanylidene-$l^{5}-phosphane Chemical compound CP(C)(Cl)=S UGOLAPHJCTVIEW-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- YRNNKGFMTBWUGL-UHFFFAOYSA-L copper(ii) perchlorate Chemical compound [Cu+2].[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O YRNNKGFMTBWUGL-UHFFFAOYSA-L 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- DZFYOYRNBGNPJW-UHFFFAOYSA-N ethoxythallium Chemical compound [Tl+].CC[O-] DZFYOYRNBGNPJW-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- YQYGPGKTNQNXMH-UHFFFAOYSA-N 4-nitroacetophenone Chemical group CC(=O)C1=CC=C([N+]([O-])=O)C=C1 YQYGPGKTNQNXMH-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 238000006359 acetalization reaction Methods 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- GWVMVHBQZQWKSU-UHFFFAOYSA-N chloro-diphenyl-sulfanylidene-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(=S)(Cl)C1=CC=CC=C1 GWVMVHBQZQWKSU-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002373 hemiacetals Chemical class 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- HSAJRDKFYZAGLU-UHFFFAOYSA-M perchloryloxymercury Chemical compound [Hg+].[O-]Cl(=O)(=O)=O HSAJRDKFYZAGLU-UHFFFAOYSA-M 0.000 description 1
- DLRJIFUOBPOJNS-UHFFFAOYSA-N phenetole Chemical compound CCOC1=CC=CC=C1 DLRJIFUOBPOJNS-UHFFFAOYSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- JUDUFOKGIZUSFP-UHFFFAOYSA-M silver;4-methylbenzenesulfonate Chemical compound [Ag+].CC1=CC=C(S([O-])(=O)=O)C=C1 JUDUFOKGIZUSFP-UHFFFAOYSA-M 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 150000003590 threoses Chemical class 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
本発明は糖のアノマー位チオホスフイン酸エス
テル誘導体とアルコールとを反応させグリコシド
系化合物を製造する方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a glycoside compound by reacting a thiophosphinate derivative at the anomeric position of a sugar with an alcohol.
グリコシド系化合物は天然にも広く分布してお
り、生理活性のある物質たとえば抗生物質、制ガ
ン剤等として医薬、農薬等の用途にも使用され注
目をあびているが、その合成には、不安定な中間
体を使用する方法や激しい反応条件を使用する方
法しか知られておらず工業的に使用できる方法は
未だ知られていない。 Glycoside compounds are widely distributed in nature, and are attracting attention as they are used as physiologically active substances, such as antibiotics and anticancer agents, in pharmaceuticals and agricultural chemicals, but their synthesis requires unstable intermediates. The only known methods are methods that use the human body or methods that use harsh reaction conditions, and no method that can be used industrially is known yet.
従来知られている方法の中ではW.Koenigおよ
びE.Knorrの方法〔Chem.Ber.34巻,957頁
(1901年、ドイツ国)参照〕が慣用される方法と
して知られている。 Among the conventionally known methods, the method of W. Koenig and E. Knorr [see Chem. Ber. vol. 34, p. 957 (1901, Germany)] is known as a commonly used method.
この方法ではハロゲノ糖とアルコールを反応さ
せるが原料のハロゲノ糖の安定性が乏しいこと、
高度に脱水した条件で反応を行なわなければなら
ないこと等欠点が多く工業化は困難である。 In this method, halogenosaccharide and alcohol are reacted, but the stability of the raw material halogenosaccharide is poor.
It has many drawbacks, such as the need to carry out the reaction under highly dehydrated conditions, making industrialization difficult.
本発明者は上記の事情に鑑み鋭意研究した結
果、特定の糖誘導体を使用すれば目的を達しうる
ことを知り本発明に到達した。 As a result of intensive research in view of the above circumstances, the present inventor found that the purpose could be achieved by using a specific sugar derivative, and arrived at the present invention.
すなわち本発明の要旨は糖のアノマー位チオホ
スフイン酸エステルとアルコールを用いるグリコ
シド系化合物の製造方法である。 That is, the gist of the present invention is a method for producing a glycoside compound using a thiophosphinic acid ester at the anomeric position of a sugar and an alcohol.
以下、本発明について詳細に説明する。 The present invention will be explained in detail below.
本発明の原料の1つ、糖のアノマー位チオホス
フイン酸エステル誘導体の原料となる糖としては
周知の糖を使用することができる。 Known sugars can be used as the raw material for the anomeric thiophosphinate derivative of sugar, which is one of the raw materials of the present invention.
これらの糖のアノマー位はヘミアセタール結合
していることが必要である。環状ヘミアセタール
は5員環であつても6員環であつてもよい。通常
アルドースを使用するがケトースも使用すること
ができる。具体的にはこれらの糖としてはエリス
ロース、スレオース等のテトラオース、リボー
ス、アラビノース、キシロース等のペントース、
グルコース、ガラクトース、マンノース、アロー
ス、タロース等のヘキソースまたはデオキシリボ
ース等これらの糖の一部がデオキシ化された糖あ
るいはN−アセチルグルコサミン等のアミノ糖更
にはこれらの糖が相互にエーテル結合したオリゴ
糖をも使用することができる。これらの糖はD
体、L体およびそれらの混合物の何れも使用する
ことができる。 It is necessary that the anomeric position of these sugars is hemiacetal bonded. The cyclic hemiacetal may be a 5-membered ring or a 6-membered ring. Usually aldoses are used, but ketoses can also be used. Specifically, these sugars include tetraoses such as erythrose and threoses, pentoses such as ribose, arabinose, and xylose;
Hexoses such as glucose, galactose, mannose, allose, and talose, or partially deoxylated sugars such as deoxyribose, amino sugars such as N-acetylglucosamine, and oligosaccharides in which these sugars are ether-linked to each other. can also be used. These sugars are D
Any of the L-isomer, L-isomer, and mixtures thereof can be used.
これらの糖のアノマー位以外の水酸基をすべて
保護することが望ましい。 It is desirable to protect all hydroxyl groups other than the anomeric positions of these sugars.
水酸基の保護基としては従来周知のものを使用
することができる。具体的にはアセチル、トリフ
ルオロアセチル、トリクロルアセチル、ベンゾイ
ル、P−ニトロベンゾイル等のアシル基で保護す
る方法、アセトアルデヒド、アセトン等でアセタ
ール化する方法、メチル、ベンジル、トリフエニ
ルメチル等の炭化水素基でエーテル化する方法等
を挙げることができる。 As the protecting group for the hydroxyl group, conventionally known ones can be used. Specifically, methods of protecting with acyl groups such as acetyl, trifluoroacetyl, trichloroacetyl, benzoyl, P-nitrobenzoyl, etc., methods of acetalization with acetaldehyde, acetone, etc., and hydrocarbon groups such as methyl, benzyl, triphenylmethyl, etc. For example, the method of etherification can be mentioned.
糖のアノマー位チオホスフイン酸エステルは上
に述べた糖誘導体を強塩基と作用させ、次いでハ
ロゲン化ホスフイノチオイルと反応させることに
より容易に合成できる。 The anomeric thiophosphinic acid ester of a sugar can be easily synthesized by reacting the above-mentioned sugar derivative with a strong base and then reacting it with a halogenated phosphinothioyl.
この方法に用いることのできるハロゲン化ホス
フイノチオイルとしては周知のものを使用するこ
とができる。すなわち、ジメチルホスフイノチオ
イル、ジエチルホスフイノチオイル、メチルフエ
ニルホスフイノチオイル、ジフエニルホスフイノ
チオイル等の各ハロゲン化物が使用できる。 As the halogenated phosphinothioyl that can be used in this method, well-known ones can be used. That is, various halides such as dimethylphosphinothioyl, diethylphosphinothioyl, methylphenylphosphinothioyl, and diphenylphosphinothioyl can be used.
ハロゲンとしてはフツ素,塩素,臭素,ヨウ素
のどれでもよいが、通常は塩化物、臭化物が使用
される。 The halogen may be any of fluorine, chlorine, bromine, and iodine, but chloride and bromide are usually used.
強塩基としては周知のものが使用できる。すな
わち金属ナトリウム、金属リチウム、金属カリウ
ム等のアルカリ金属類、ナトリウムメトキシド、
タリウムエトキシド等の金属アルコラート類、水
素化ナトリウム等のアルカリ金属水素化類、n−
ブチルリチウム、フエニルリチウム等のアルキル
またはアリール金属類あるいは1,8−ジアザビ
シクロ−〔5,4,0〕−ウンデセン−7等の強塩
基性アミン類等である。 As the strong base, well-known ones can be used. That is, alkali metals such as metallic sodium, metallic lithium, metallic potassium, sodium methoxide,
Metal alcoholates such as thallium ethoxide, alkali metal hydrides such as sodium hydride, n-
These include alkyl or aryl metals such as butyllithium and phenyllithium, and strong basic amines such as 1,8-diazabicyclo-[5,4,0]-undecene-7.
ハロゲン化ホスフイノチオイルと強塩基は、糖
に対して大過剰に用いることも可能であるが通常
は1〜2モル等量である。 Although it is possible to use the halogenated phosphinothioyl and the strong base in large excess relative to the sugar, the amount is usually 1 to 2 molar equivalents.
溶媒としては特に制限はない。すなわち、ベン
ゼン、トルエン、クロロホルム、ジクロルメタ
ン、酢酸エチル、テトラヒドロフラン、ジメチル
ホルムアミド、アセトニトリル、ニトロメタン等
を挙げることができる。 There are no particular restrictions on the solvent. That is, benzene, toluene, chloroform, dichloromethane, ethyl acetate, tetrahydrofuran, dimethylformamide, acetonitrile, nitromethane and the like can be mentioned.
反応温度は−60℃から溶媒の沸点まで特に制限
はない。 The reaction temperature is not particularly limited from -60°C to the boiling point of the solvent.
糖のアノマー位チオホスフイン酸エステルには
α体とβ体が存在するがこれらは混合物から分離
することも可能であるが、溶媒、塩基、反応温度
等を変えることにより選択性よく製造することも
可能である。一方、グリコシル化反応の原料とし
てはα体,β体のいずれでも、また、これらの混
合物でも使用できる。 Anomeric thiophosphinates of sugars exist in α and β forms, which can be separated from a mixture, but they can also be produced with good selectivity by changing the solvent, base, reaction temperature, etc. It is. On the other hand, as a raw material for the glycosylation reaction, either the α-form, the β-form, or a mixture thereof can be used.
本発明方法の他の原料として使用されるアルコ
ールとしては周知のものを使用することができ
る。すなわち脂肪族アルコール、芳香族アルコー
ル、ステロイドアルコール、グリセロール誘導
体、糖誘導体、アミノ酸誘導体など水酸基を有す
る化合物を使用することができる。 As the alcohol used as another raw material in the method of the present invention, well-known alcohols can be used. That is, compounds having hydroxyl groups such as aliphatic alcohols, aromatic alcohols, steroid alcohols, glycerol derivatives, sugar derivatives, and amino acid derivatives can be used.
脂肪族アルコールとしてはメタノール、エタノ
ール、プロパノール、イソプロパノール、セチル
アルコール、ブタノール、エチレングリコール、
プロピレングリコール等を挙げることができる。
勿論、シクロヘキサノール、メチルシクロヘキサ
ノール、メントール等環状脂肪族アルコールも使
用できることは言うまでもない。 Aliphatic alcohols include methanol, ethanol, propanol, isopropanol, cetyl alcohol, butanol, ethylene glycol,
Examples include propylene glycol.
Needless to say, cycloaliphatic alcohols such as cyclohexanol, methylcyclohexanol, and menthol can also be used.
芳香族アルコールとしてはフエノール、p−ク
ロロフエノール、o−クロロフエノール、フエネ
トール、p−ニトロフエノール、o−ニトロフエ
ノール、2,4−ジニトロフエノール、p−クレ
ゾール、o−クレゾール、α−ナフトール、β−
ナフトール、カテコール、レゾルシノール、ハイ
ドロキノン等を挙げることができる。 Aromatic alcohols include phenol, p-chlorophenol, o-chlorophenol, phenetol, p-nitrophenol, o-nitrophenol, 2,4-dinitrophenol, p-cresol, o-cresol, α-naphthol, β-
Naphthol, catechol, resorcinol, hydroquinone, etc. can be mentioned.
ステロイドアルコールとしてはコレステロー
ル、コレスタノール、スチグマステロール、カン
ペステロール、シトステロール、エルゴステロー
ル、フコステロール、エストロン、エストラジオ
ール、テストステロン、アンドロステロン等を挙
げることができる。 Examples of steroid alcohols include cholesterol, cholestanol, stigmasterol, campesterol, sitosterol, ergosterol, fucosterol, estrone, estradiol, testosterone, androsterone, and the like.
グリセロール誘導体としてはグリセリン及びそ
のモノアシル体を前述した保護基で保護したもの
やグリセリンのジアシル体を挙げることができ
る。ここでアシル基としてはアセチル、ベンゾイ
ル、パルミチル、ステアリル、オレイル等を挙げ
ることができ、ジアシル体では同一のアシル基で
も異なるアシル基でもよい。 Examples of glycerol derivatives include glycerin and its monoacyl derivatives protected with the above-mentioned protecting groups, and glycerin diacyl derivatives. Here, examples of the acyl group include acetyl, benzoyl, palmityl, stearyl, oleyl, etc., and diacyl groups may be the same or different acyl groups.
糖誘導体としては周知のものが使用できる。す
なわち前述した糖が使用できるが、必ずしもヘミ
アセタール結合している必要はない。 Well-known sugar derivatives can be used. That is, the sugars mentioned above can be used, but they do not necessarily have to be hemiacetal linked.
また、オリゴ糖が使用できることは言うまでも
ない。 It goes without saying that oligosaccharides can also be used.
糖には数多くの水酸基が存在するが、できるだ
け保護することが望ましい。保護基としては前述
したものが使用できる。 Sugars have many hydroxyl groups, and it is desirable to protect them as much as possible. As the protecting group, those mentioned above can be used.
アミノ酸誘導体としては、セリン、スレオニ
ン、ヒドロキシプロリン、ヒドロキシリジン、チ
ロシン等を挙げることができる。これらのアミノ
酸にはL−体とD−体が存在するがその何れでも
又、混合物でもかまわない。また、アミノ酸のカ
ルボキシル基を還元して得られるアミノアルコー
ルやアミノ酸が縮合したペプチドを使用できるこ
とは言うまでもない。更に、アミノ酸のアミノ基
やカルボキシル基等を周知の方法で保護したもの
も使用できる。 Examples of amino acid derivatives include serine, threonine, hydroxyproline, hydroxylysine, and tyrosine. These amino acids exist in L-form and D-form, and either one or a mixture may be used. It goes without saying that amino alcohols obtained by reducing the carboxyl groups of amino acids and peptides in which amino acids are condensed can also be used. Furthermore, amino acids whose amino groups, carboxyl groups, etc. are protected by well-known methods can also be used.
つづいて本発明方法である糖のアノマー位チオ
ホスフイン酸エステルとアルコールとの反応につ
いて説明する。この方法では両者のモル比は特に
制限はなくアルコールを大過剰に用いてもよい
や、通常は1〜数倍モル等量である。 Next, the reaction of the anomeric thiophosphinic acid ester of sugar and alcohol, which is the method of the present invention, will be explained. In this method, the molar ratio of the two is not particularly limited, and the alcohol may be used in large excess, and is usually one to several times the molar equivalent.
溶媒としてはアルコール系の溶媒を使用できな
い事は言うまでもない。他の溶媒たとえばベンゼ
ン、トルエン、ジクロルメタン、クロロホルム、
テトラヒドロフラン、ジメチルホルムアミド等を
使用することができるが、好ましくはテトラヒド
ロフラン、ベンゼン等の溶媒を使用する。 Needless to say, alcohol-based solvents cannot be used as the solvent. Other solvents such as benzene, toluene, dichloromethane, chloroform,
Tetrahydrofuran, dimethylformamide, etc. can be used, but preferably a solvent such as tetrahydrofuran, benzene, etc. is used.
反応温度は特に制限はないが、通常は−20℃〜
40℃好ましくは−10℃〜25℃である。 There is no particular restriction on the reaction temperature, but it is usually -20℃~
40°C, preferably -10°C to 25°C.
反応時間は反応温度、原料の種類等によつて異
なるが、数分〜数時間の範囲である。 The reaction time varies depending on the reaction temperature, the type of raw materials, etc., but is in the range of several minutes to several hours.
反応を行なうにあたつてはアルコール成分に対
し、等モルあるいは過剰モルの周知の銀塩あるい
は銅塩あるいは水銀塩の存在下で行なう。周知の
銀塩あるいは銅塩あるいは水酸塩としては過塩素
酸銀、酢酸銀、トリフルオロメタンスルホン酸
銀、p−トルエンスルホン酸銀、硝酸銀、過塩素
酸銅、過塩素酸水銀、酢酸水銀等を挙げることが
できるが好ましくは過塩素酸銀、過塩素酸銅を使
用する。これらの金属塩は特に無水状態にするこ
となく反応系にモレキユラーシーブ等の脱水剤を
共存させるだけで充分である。 The reaction is carried out in the presence of a known silver salt, copper salt or mercury salt in an equimolar or excess molar amount to the alcohol component. Well-known silver salts, copper salts or hydroxides include silver perchlorate, silver acetate, silver trifluoromethanesulfonate, silver p-toluenesulfonate, silver nitrate, copper perchlorate, mercury perchlorate, mercury acetate, etc. Silver perchlorate and copper perchlorate are preferably used. It is sufficient to use these metal salts in the presence of a dehydrating agent such as a molecular sieve in the reaction system without making them particularly anhydrous.
本発明方法はこのように有用な化合物を収率良
く、緩和な中性条件下で製造でき、副生成物も少
なく、その工業的価値は大である。 As described above, the method of the present invention can produce useful compounds in good yields under mild neutral conditions, produces few by-products, and has great industrial value.
以下に実施例を挙げて本発明を更に具体的に説
明するが本発明はその要旨を超えない限り、以下
の実施例により何等の制限も受けるものではな
い。 The present invention will be described in more detail below with reference to Examples, but the present invention is not limited in any way by the Examples unless it exceeds the gist thereof.
実施例 1
2,3,4,6−テトラベンジル−D−グルコ
ピラノースジメチルチオホスフイン酸エステル
126.5g(0.2mmol)をテトラヒドロフラン(1
ml)に溶解させメタノール16μ(0.4mmol)と
過塩素酸銀0.207mg(1mmol)を加え室温で30分
撹拌した。溶媒を減圧留去した後調整用シリカゲ
ル薄層クロマト(展開剤;n−ヘキサン:酢酸エ
チル=3:1)で精製したところメチル2,3,
4,6−テトラベンジル−D−グルコピラノシド
が油状物質として91.5mg(83モル%)得られた。
NMR((CDCl3,ppm);3.39(S,3H,
7.23(S,
7.33(S,20H,Ph)
実施例 2
実施例1の過塩素酸銀の代りに硝酸銀0.170g
(1mmol)用い全く同様に反応させたところ、
メチル2,3,4,6−テトラベンジル−D−グ
ルコピラノシドが油状物質として23.0mg(20モル
%)得られた。NMRは実施例1と一致した。Example 1 2,3,4,6-tetrabenzyl-D-glucopyranose dimethylthiophosphinic acid ester
126.5g (0.2mmol) of tetrahydrofuran (1
ml), 16 μm (0.4 mmol) of methanol and 0.207 mg (1 mmol) of silver perchlorate were added, and the mixture was stirred at room temperature for 30 minutes. After the solvent was distilled off under reduced pressure, purification using preparative silica gel thin layer chromatography (developing agent: n-hexane: ethyl acetate = 3:1) yielded methyl 2,3,
91.5 mg (83 mol%) of 4,6-tetrabenzyl-D-glucopyranoside was obtained as an oily substance.
NMR ((CDCl 3 , ppm); 3.39 (S, 3H, 7.23 (S, 7.33 (S, 20H, Ph)) Example 2 Silver nitrate 0.170 g instead of silver perchlorate in Example 1
(1 mmol) and reacted in exactly the same way,
23.0 mg (20 mol %) of methyl 2,3,4,6-tetrabenzyl-D-glucopyranoside was obtained as an oily substance. NMR was consistent with Example 1.
実施例 3
実施例1のメタノールの代りにβ−コレスタノ
ール72.7mg(0.2mmol)を用い同様に反応させ、
調整用シリカゲル薄層クロマト(展開剤;n−ヘ
キサン:エーテル=4:1)で精製したところβ
−コレスタニル2,3,4,6−テトラベンジル
−D−グルコピラノシドが油状物質として62.7mg
(34モル%)得られた。NMR(CDCl3,ppm);
0.40−2.43(m,47H,コレスタニルCH3,CH2,
CH)
7.24(S,
7.33(S,20H,Ph)
実施例 4
実施例1のβ−コレスタノールの代りにシクロ
ヘキサノール20mg(0.2mmol)を用い、同様に処
理すると、シクロヘキシル2,3,4,6−テト
ラベンジル−D−グルコピラノシドが油状物質と
して59.7mg(49モル%)得られた。Example 3 A reaction was carried out in the same manner as in Example 1 using 72.7 mg (0.2 mmol) of β-cholestanol instead of methanol.
Purification using silica gel thin layer chromatography (developing agent: n-hexane:ether = 4:1) resulted in β
- 62.7 mg of cholestanil 2,3,4,6-tetrabenzyl-D-glucopyranoside as an oily substance
(34 mol%) was obtained. NMR (CDCl 3 , ppm);
0.40−2.43(m, 47H, cholestanil CH 3 , CH 2 ,
CH) 7.24 (S, 7.33 (S, 20H, Ph) Example 4 Using 20 mg (0.2 mmol) of cyclohexanol in place of β-cholestanol in Example 1 and treating in the same manner, cyclohexyl 2,3,4, 59.7 mg (49 mol %) of 6-tetrabenzyl-D-glucopyranoside was obtained as an oily substance.
実施例 5
実施例1と同様に2,3,4,6−テトラベン
ジル−α−D−グルコピラノースジフエニルチオ
ホスフイン酸エステル75.7mg(0.2mmol)を用い
行なつたところ、メチル2,3,4,6−テトラ
ベンジル−D−グルコピラノシドが油状物質とし
て82.3mg(75モル%)得られた。Example 5 In the same manner as in Example 1, 75.7 mg (0.2 mmol) of 2,3,4,6-tetrabenzyl-α-D-glucopyranose diphenylthiophosphinic acid ester was used. , 82.3 mg (75 mol %) of 4,6-tetrabenzyl-D-glucopyranoside was obtained as an oily substance.
実施例 6
2,3,4,6−テトラベンジル−α−D−グ
ルコピラノースジメチルチオホスフイン酸エステ
ル63.3mg(0.1mmol)、β−コレスタノール38.9mg
(0.1mmol)、モレキユラーシーブス4A約100mg、
ベンゼン0.5mlの混合物に撹拌しながら過塩素酸
銀20.7mg(0.1mmol)をベンゼン1mlを用い加え
た。一夜反応させ、5%硫化ナトリウム水溶液を
加え、不溶物を別した。液をエーテルで2回
抽出し、エーテル層を水洗、乾燥した。溶媒を減
圧留去し、得られる油状物質を調整用シリカゲル
薄層クロマトで分離精製したところ、β−コレス
タニル2,3,4,6−テトラベンジル−α−D
−グルコピラノシドが白色結晶として65.0mg(71
モル%)得られた。融点117.5−119.0℃。Example 6 2,3,4,6-tetrabenzyl-α-D-glucopyranose dimethylthiophosphinic acid ester 63.3 mg (0.1 mmol), β-cholestanol 38.9 mg
(0.1 mmol), about 100 mg of molecular sieves 4A,
20.7 mg (0.1 mmol) of silver perchlorate was added to a mixture of 0.5 ml of benzene with stirring using 1 ml of benzene. After reacting overnight, a 5% aqueous sodium sulfide solution was added to remove insoluble materials. The liquid was extracted twice with ether, and the ether layer was washed with water and dried. The solvent was distilled off under reduced pressure, and the resulting oily substance was separated and purified using preparative silica gel thin layer chromatography.
- Glucopyranoside as white crystals 65.0 mg (71
% by mole) was obtained. Melting point 117.5-119.0℃.
また、対応するβ−グリコシドが白色結晶とし
て15.9mg(17モル%)得られた。融点93.5℃。 In addition, 15.9 mg (17 mol%) of the corresponding β-glycoside was obtained as white crystals. Melting point: 93.5℃.
実施例 7
実施例6のβ−コレスタノールの代りにメチル
2,3,4−トリベンジル−α−D−グルコピラ
ノシド92.9mg(0.2mmol)を用い、ジメチルチオ
ホスフイン酸エステル誘導体126.5mg
(0.2mmol)、過塩素酸銀41.5mg(0.2mmol)、ベ
ンゼン2mlを使用して同様に行なつたところ、メ
チル2,3,4−トリベンジル−6−(2,3,
4,6−テトラベンジル−α−D−グルコピラノ
シル)−α−D−グルコピラノシドが白色結晶と
して120.6mg(61モル%)得られた。融点101℃。
また、対応するβ−アノマーが15.5mg(8モル
%)得られた。Example 7 92.9 mg (0.2 mmol) of methyl 2,3,4-tribenzyl-α-D-glucopyranoside was used in place of β-cholestanol in Example 6, and 126.5 mg of dimethylthiophosphinate derivative was used.
(0.2 mmol), silver perchlorate 41.5 mg (0.2 mmol), and benzene 2 ml, methyl 2,3,4-tribenzyl-6-(2,3,
120.6 mg (61 mol%) of 4,6-tetrabenzyl-α-D-glucopyranosyl-α-D-glucopyranoside was obtained as white crystals. Melting point: 101℃.
In addition, 15.5 mg (8 mol%) of the corresponding β-anomer was obtained.
実施例 8
実施例7と同様に、メチル2,3,6−トリベ
ンジル−α−D−グルコピラノシド92.9mg
(0.2mmol)、ジメチルチオホスフイン酸エステル
誘導体253.0mg(0.4mmol)、過塩素酸銀83.0mg
(0.4mmol)を用い行なつたところ、メチル2,
3,6−トリベンジル−4−(2,3,4,6−
テトラベンジル−α−D−グルコピラノシル)−
α−D−グルコピラノシドが油状物質として
145.9mg(74モル%)得られた。NMR;3.34ppm
(S,3H,OCH3),6.93−7.50ppm(m,35H,
Ph)。また対応するβ−アノマーが油状物質とし
て15.8mg(8モル%)得られた。Example 8 Same as Example 7, 92.9 mg of methyl 2,3,6-tribenzyl-α-D-glucopyranoside
(0.2 mmol), dimethylthiophosphinate derivative 253.0 mg (0.4 mmol), silver perchlorate 83.0 mg
(0.4 mmol), methyl 2,
3,6-tribenzyl-4-(2,3,4,6-
Tetrabenzyl-α-D-glucopyranosyl)-
α-D-glucopyranoside as an oily substance
145.9 mg (74 mol%) was obtained. NMR; 3.34ppm
(S, 3H, OCH 3 ), 6.93-7.50ppm (m, 35H,
Ph). In addition, 15.8 mg (8 mol %) of the corresponding β-anomer was obtained as an oily substance.
参考例 1
2,3,4,6−テトラベンジル−D−グルコ
ピラノース2.70mg(5mmol)をテトラヒドロフラ
ン(20ml)に溶解させ、窒素雰囲気下、−30℃に
冷却する。これに1.6Mn−ブチルリチウム/n−
ヘキサン溶液を3.4ml(5.4mmol)加え、10分後
塩化ジメチルホスフイノチオイル0.69g
(5.4mmol)を加える。反応溶液を−30℃で3時
間撹拌した後室温に戻す。これにエーテルと水を
加え分液しエーテル層を水洗乾燥後減圧濃縮する
と3.71gの油状物質が得られる。これをジクロル
メタンを溶出液とするシリカゲルカラムクロマト
(2.5×42cm)により精製すると2,3,4,6−
テトラベンジル−D−グルコピラノースジメチル
チオホスフイン酸エステルが白色結晶として2.41
g(76モル%)得られた。α体とβ体の比は98:
2であつた。n−ヘキサンでデカンテーシヨンす
ると2,3,4,6−テトラベンジル−α−D−
グルコピラノースジメチルチオホスフイン酸エス
テルが得られた。融点62−64℃
NMR(CDCl3,ppm)
1.86(d,6H,p−CH3,J=13Hz)6.18
(d,d,1H,H−1,J=13Hz,3Hz)
7.23(S,
7.30(S,20H,Ph)
参考例 2
2,3,4,6−テトラベンジル−D−グルコ
ピラノース2.38g(4.4mmol)をテトラヒドロフ
ラン20mlに溶解させ、0℃で、1.6Mn−ブチルリ
チウム/n−ヘキサン溶液2.75ml(4.8mmol)
と、塩化ジメチルホスフイノチオイル0.62g
(4.8mmol)を用い。参考例1と同様に行なつた。
ジクロルメタンを溶出液とするシリカゲルカラム
クロマト(2.5×30cm)で精製すると2,3,4,
6−テトラベンジル−D−グルコピラノースジメ
チルチオホスフイン酸エステルが油状物質として
2.78g(99モル%)得られた。NMRより求めた
α体とβ体の比は50:50であつた。Reference Example 1 2.70 mg (5 mmol) of 2,3,4,6-tetrabenzyl-D-glucopyranose is dissolved in tetrahydrofuran (20 ml) and cooled to -30°C under a nitrogen atmosphere. To this, 1.6Mn-butyllithium/n-
Add 3.4ml (5.4mmol) of hexane solution and after 10 minutes 0.69g of dimethylphosphinothioyl chloride
(5.4 mmol). The reaction solution was stirred at -30°C for 3 hours and then returned to room temperature. Ether and water are added to this to separate the layers, and the ether layer is washed with water, dried, and concentrated under reduced pressure to obtain 3.71 g of an oily substance. When this was purified by silica gel column chromatography (2.5 x 42 cm) using dichloromethane as the eluent, 2,3,4,6-
Tetrabenzyl-D-glucopyranose dimethylthiophosphinate as white crystals at 2.41
g (76 mol%) was obtained. The ratio of α and β forms is 98:
It was 2. Decantation with n-hexane yields 2,3,4,6-tetrabenzyl-α-D-
Glucopyranose dimethylthiophosphinate was obtained. Melting point 62-64℃ NMR (CDCl 3 , ppm) 1.86 (d, 6H, p-CH 3 , J=13Hz) 6.18
(d, d, 1H, H-1, J = 13Hz, 3Hz) 7.23 (S, 7.30 (S, 20H, Ph) Reference example 2 2,3,4,6-tetrabenzyl-D-glucopyranose 2.38g ( Dissolve 4.4 mmol) in 20 ml of tetrahydrofuran, and add 2.75 ml (4.8 mmol) of 1.6M n-butyllithium/n-hexane solution at 0°C.
and 0.62 g of dimethylphosphinothioyl chloride.
(4.8 mmol) was used. The same procedure as in Reference Example 1 was carried out.
When purified by silica gel column chromatography (2.5 x 30 cm) using dichloromethane as eluent, 2, 3, 4,
6-tetrabenzyl-D-glucopyranose dimethylthiophosphinic acid ester as an oily substance
2.78 g (99 mol%) was obtained. The ratio of α-form and β-form determined by NMR was 50:50.
参考例 3
2,3,4,6−テトラベンジル−D−グルコ
ピラノース1.08g(2mmol)をベンゼン10mlとテ
トラヒドロフラン10mlの混合溶液に溶解させた。
これに窒素を通じながらタリウムエトキシド0.15
ml(2.1mmol)を加え室温で15分撹拌した。溶媒
を減圧留去し、乾燥後ベンゼン10mlに再び溶解さ
せつづいて塩化ジメチルホスフイノチオイル0.28
g(2.2mmol)を加え4時間反応させた。その後
参考例1と同様に精製すると2,3,4,6−テ
トラベンジル−D−グルコピラノースジメチルチ
オホスフイン酸エステルが白色結晶として0.38g
(30モル%)得られた。NMRより求めたα体と
β体の比は9:91であり、n−ヘキサンでデカン
テーシヨンすることで2,3,4,6−テトラベ
ンジル−β−D−グルコピラノースジメチルチオ
ホスフイン酸エステルが得られた。融点76−77℃
NMR(CDCl3,ppm)
1.85(d,d,6H,p−CH3,J=13Hz,
8Hz)5.37(d.d,1H,H−1,J=13Hz,
7Hz)
7.26(S,
7.28(S,
7.30(S,20H,Ph)
参考例 4
2,3,4,6−テトラベンジル−D−グルコ
ピラノース108.1mg(0.2mmol),20%n−ブチル
リチウム/n−ヘキサン溶液103.1μ
(0.22mmol),塩化ジフエニルホスフイノチオイ
ル55.6mg(0.22mmol)、テトラヒドロフラン1ml
を用い、参考例1と同様に行なつた。シリカゲル
薄層クロマト(20×20cm)を用い精製したとこ
ろ、2,3,4,6−テトラベンジル−α−D−
グルコピラノースジフエニルチオホスフイン酸エ
ステルが油状物質として81.3mg(55モル%)得ら
れた。Reference Example 3 1.08 g (2 mmol) of 2,3,4,6-tetrabenzyl-D-glucopyranose was dissolved in a mixed solution of 10 ml of benzene and 10 ml of tetrahydrofuran.
Add 0.15 thallium ethoxide while passing nitrogen through this.
ml (2.1 mmol) was added and stirred at room temperature for 15 minutes. The solvent was distilled off under reduced pressure, and after drying, it was dissolved again in 10 ml of benzene, followed by dimethylphosphinothioyl chloride (0.28 g).
g (2.2 mmol) was added and reacted for 4 hours. Thereafter, when purified in the same manner as in Reference Example 1, 0.38 g of 2,3,4,6-tetrabenzyl-D-glucopyranose dimethylthiophosphinic acid ester was obtained as white crystals.
(30 mol%) was obtained. The ratio of α and β forms determined by NMR was 9:91, and by decanting with n-hexane, 2,3,4,6-tetrabenzyl-β-D-glucopyranose dimethylthiophosphinic acid was obtained. An ester was obtained. Melting point 76-77℃ NMR (CDCl 3 , ppm) 1.85 (d, d, 6H, p-CH 3 , J=13Hz,
8Hz) 5.37 (dd, 1H, H-1, J=13Hz,
7Hz) 7.26 (S, 7.28 (S, 7.30 (S, 20H, Ph)) Reference example 4 2,3,4,6-tetrabenzyl-D-glucopyranose 108.1 mg (0.2 mmol), 20% n-butyllithium/ n-hexane solution 103.1μ
(0.22mmol), diphenylphosphinothioyl chloride 55.6mg (0.22mmol), tetrahydrofuran 1ml
The same procedure as in Reference Example 1 was carried out using . When purified using silica gel thin layer chromatography (20 x 20 cm), 2,3,4,6-tetrabenzyl-α-D-
81.3 mg (55 mol%) of glucopyranose diphenylthiophosphinic acid ester was obtained as an oily substance.
NMR(CDCl3,ppm)
6.38(dd,1H,H−1,J=13Hz,3Hz)
6.98−8.26(m,30H,Ph) NMR (CDCl 3 , ppm) 6.38 (dd, 1H, H-1, J = 13Hz, 3Hz)
6.98−8.26 (m, 30H, Ph)
Claims (1)
のアノマー位の水酸基の水素が一般式〔〕 (式中R1、R2はメチル基、エチル基、プロピ
ル基、イソプロピル基、ブチル基、s−ブチル
基、t−ブチル基、フエニル基、p−メトキシフ
エニル基のいずれかを示す。)で表される糖のア
ノマー位チオホスフイン酸エステル誘導体と、脂
肪族アルコール、芳香族アルコール、ステロイド
アルコール、グリセロール誘導体、糖誘導体、ア
ミノ酸誘導体から選ばれるアルコールとを、銀塩
あるいは銅塩あるいは水銀塩を共存させ反応させ
ることを特徴とするグリコシド系化合物の製造方
法。 2 糖のアノマー位チオホスフイン酸エステル誘
導体が糖のアノマー位ジメチルチオホスフイン酸
エステル誘導体であることを特徴とする特許請求
の範囲第1項記載の製造方法。 3 糖のアノマー位チオホスフイン酸エステル誘
導体が糖のアノマー位ジフエニルチオホスフイン
酸エステル誘導体であることを特徴とする特許請
求の範囲第1項記載の製造方法。 4 銀塩として過塩素酸銀を用いることを特徴と
する特許請求の範囲第1項記載の製造方法。[Scope of Claims] 1 The hydrogen of the hydroxyl group at the anomeric position of a sugar whose anomeric position is hemiacetal bonded has the general formula [] (In the formula, R 1 and R 2 represent either a methyl group, ethyl group, propyl group, isopropyl group, butyl group, s-butyl group, t-butyl group, phenyl group, or p-methoxyphenyl group.) An anomeric thiophosphinic acid ester derivative of a sugar represented by the formula and an alcohol selected from aliphatic alcohols, aromatic alcohols, steroid alcohols, glycerol derivatives, sugar derivatives, and amino acid derivatives are coexisted with silver salts, copper salts, or mercury salts. 1. A method for producing a glycoside compound, which comprises causing a reaction. 2. The production method according to claim 1, wherein the thiophosphinate derivative at the anomeric position of a sugar is a dimethylthiophosphinate derivative at the anomeric position of a sugar. 3. The production method according to claim 1, wherein the thiophosphinate derivative at the anomeric position of a sugar is a diphenylthiophosphinate derivative at the anomeric position of a sugar. 4. The manufacturing method according to claim 1, characterized in that silver perchlorate is used as the silver salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13905783A JPS60136591A (en) | 1983-07-29 | 1983-07-29 | Preparation of glycoside compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13905783A JPS60136591A (en) | 1983-07-29 | 1983-07-29 | Preparation of glycoside compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60136591A JPS60136591A (en) | 1985-07-20 |
JPH0460120B2 true JPH0460120B2 (en) | 1992-09-25 |
Family
ID=15236475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13905783A Granted JPS60136591A (en) | 1983-07-29 | 1983-07-29 | Preparation of glycoside compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60136591A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0699460B2 (en) * | 1989-03-27 | 1994-12-07 | 財団法人野口研究所 | Process for producing 2-deoxy-aldose glycoside compound |
-
1983
- 1983-07-29 JP JP13905783A patent/JPS60136591A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60136591A (en) | 1985-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0676432B2 (en) | Method for selective methylation of erythromycin A derivative | |
JP3231765B2 (en) | Method for producing demethyl epipodophyllotoxin | |
FR2600066A1 (en) | NOVEL ANTHRACYCLINE GLYCOSIDES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS ANTI-TUMOR AGENTS | |
JP2001527568A (en) | Novel glycosylated derivative of gingolide, its use as medicament and pharmaceutical composition containing it | |
BE1000407A4 (en) | Anthracycline glycosides antitumor activity, preparation, the intermediate compounds of that preparation, and composition and use of these substances. | |
JPH0460120B2 (en) | ||
KR100211417B1 (en) | L-talopyranoside derivatives and process for the production of same | |
Binkley et al. | Participation by C-3 Substituents in Disaccharide Formation | |
JPH0460119B2 (en) | ||
EP0819697A2 (en) | 1-C-perfluoroalkyl glycosides, method of preparation and use | |
JPH0460118B2 (en) | ||
JP2774429B2 (en) | Branched-chain derivatives having a sugar skeleton | |
JPH03264595A (en) | Novel glycosylation method | |
JP2629852B2 (en) | Method for producing glycosyl compound | |
JP3553989B2 (en) | Novel glycosyl donor and method for producing glycoside compound using the same | |
JPH0261960B2 (en) | ||
KR920000620B1 (en) | New anthracycline glycosides derivatives | |
JP4162739B2 (en) | Process for producing glycoside derivatives | |
KR0133726B1 (en) | Novel anthracycline glycoside derivatives | |
WO2022191312A1 (en) | Novel dealkoxyphenylation reaction | |
GB2071658A (en) | Synthesis of daunosamine hydrochloride and intermediates used in its preparation | |
JPH0686472B2 (en) | O-glycoside type glycolipid having serine long-chain alkyl derivative as hydrophobic part | |
JP2001081097A (en) | Hinokition acetoglucoside and its production | |
JP2002525375A (en) | Method for synthesizing urosonic acid C-glycoside | |
JP2004099575A (en) | New d-galactosamine derivative and synthetic method for mucin core 2 class by using the same |